George Simeon's Form 4 filing
eFFECTOR Therapeutics, Inc.EFTR · filed Nov 29, 2023
- Accession no.
- 0001209191-23-056920
- Filed
- Nov 29, 2023, 5:07 PM ET
- Trade date
- Nov 27, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $369.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| George SimeonCIK 0001595117 | 10% Owner |
| SR One Capital Fund I Aggregator LPCIK 0001848319 | 10% Owner |
| Sr One Capital Management, LLCCIK 0001853723 | 10% Owner |
| Sr One Capital Partners I, LPCIK 0001853724 | 10% Owner |
| SR One Co-Invest I, LLCCIK 0001864915 | 10% Owner |
| SR One Co-Invest I Manager, LLCCIK 0001881204 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.5691 to $0.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 2 transactions in Table I.